Ipca is a fully integrated, rapidly growing Indian pharmaceutical company with a strong thrust on export.

Lead preparation, review, and control of SOPs, master documents, protocols, and reports for the packaging department.

Otsuka Pharmaceutical India Private Limited is primarily manufacturing IV and parenteral nutrition products across multiple markets and therapeutic segments.

Train and develop the scientific knowledge, selling skill and performance orientation for large field force of Cardio and Diabetic division.

Environmental and Microbial Monitoring, including compressed gases and microbial limit testing, qualification, requalification, aseptic techniques, documentation etc.

Well versed with Analytical methods validation/Method transfer/Cleaning validation, Handling HPLC, GC, DR and other instruments, Reviewing analytical data. Preparation of Validation protocols and reports.

Lauryl Lactyl Lactate (L3), also known as Koplactylate, is a naturally-derived, multi-functional ingredient used in personal care and cosmetics. It acts as an emollient, surfactant, and emulsifier, improving texture, stability, and feel in products like creams, lotions, shampoos, and conditioners. L3 is derived from lauryl alcohol and lactic acid through esterification.

In a landmark study published recently in Chinese Neurosurgical Journal, Chinese researchers have identified the protein FAM111B as a crucial molecular accelerator in glioma, the most common and deadly form of primary brain cancer in adults.

Researchers at the University of Texas at Arlington (UTA) have identified a novel molecular mechanism by which chronic inflammation impairs cholesterol metabolism, potentially paving the way for new therapeutic strategies targeting inflammatory diseases and cardiovascular disorders.

In a significant development for global health, Hyderabad-based Biological E. Limited has joined hands with Chinese biopharmaceutical firm Jiangsu Recbio Technology Company Limited to produce and distribute the 9-valent Human Papillomavirus (HPV9) vaccine, REC603.

Alembic Pharmaceuticals Limited has announced that it has received final approval from the U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Doxorubicin Hydrochloride Liposome Injection in two strengths: 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL) single-dose vials.

Masters in Biostatistics or Statistics or Epidemiology or Public Health or Clinical Research or Pharmacology or equivalent. 

Masters in Natural or Agricultural or Pharmaceutical Sciences. Characterizing the properties and structure of aramid and carbon fibers for industrial applications.

Masters degree, Ph.D in Public Health, Epidemiology, Life Sciences. OR Health Care Management, Health Administration after MBBS, BHMS, BDS or any other medical professional course in health Science.

Masters degree in Life Sciences with two years research experience in Microbiology / Molecular Biology / Biotechnology. 

M.Sc, M.Tech in Biotechnology, Microbiology, Biochemistry, Bioinformatics or any other relevant life science discipline with minimum 55% marks or equivalent CGPA obtained.

Basic knowledge of computer work and ability to support routine R&D work in laboratory working in the area of Plant Science, Biotechnology, Life Sciences.

Masters in Bioinformatics or Computational Biology from a recognized University.

Candidates from Medical Sciences, Biological Sciences, Chemical Sciences, Chemistry, Physical Sciences, Mathematics and Information Sciences are eligible to apply.